LATEST NEWS AND EVENTS

News

Another achievement to bring Radiotheranostics forward

300 hospitals registered on the Oncidium foundation Map! Another achievement to bring Radiotheranostics forward and strive for access education and hope. Thank you to...

News

NET Patient Testimonial, how PRRT saved Tom’s life

Tom is a composer, pianist, audio producer and neuroendocrine tumor patient. When he was diagnosed with NET's, he didn't know that PRRT could save his life...

News

Diagnostic accuracy of 18 F-PSMA-1007-PET/CT imaging for prostate carcinoma

J. Nucl. Me. 2020 Aug 17 18F-PSMA-1007-PET/CT reliably detects malignant lymph nodes and has an exceptional specificity of >99% for nodal metastases. Congratulations for this...

Events

IPET 2020 – all you need to know about Theranostics

Event: IPET 2020, Beyond the visible - International Conference on Molecular Imaging and Clinical PET-CT in the Era of Theranostics Date: 24-26 November 2020 Don't miss...

News

Radiopharmaceuticals Emerging as New Cancer Therapy

National cancer Institute. October 26, 2020 The last years have seen an explosion of research and clinical trials testing new radiopharmaceuticals suggesting that targeting radiation...

News

October Rose – Breast Cancer Awareness Month

The Oncidium foundation wears the colors of October Rose. Breast Cancer is by far the most common cancer in women worldwide, both in developed...

Events

EANM ’20 – Let’s talk Radiotheranostics!

Event: EANM 2020 Annual Meeting - Virtual Edition Date: 22-30 October 2020 This year, the Oncidium foundation team looks forward to meeting you “virtually” at the EANM...

News

Nuclear Medicine and Molecular Imaging Week: October 4-10, 2020

October 4-10 2020 is nuclear medicine and molecular imaging week! A great initiative by Society of Nuclear Medicine and Molecular Imaging (SNMMI) to raise...

News

First clinical results for PSMA TAT using Ac-225-PSMA-I&T in advanced mCRPC patients

First clinical results for PSMA targeted alpha therapy using 225Ac-PSMA-I&T in advanced metastatic castration resistant prostate cancer patients: promising antitumor effect in advanced mCRPC...

News

IAEA activities on Cu-67, Re-186, Sc-47 Theranostic radionuclides and Radiopharmaceuticals

International Atomic Energy Agency (IAEA) activities on 67Cu, 186Re, 47Sc Theranostic radionuclides and Radiopharmaceuticals: Extraordinary results on the production, quality control and preclinical evaluation...

News

The Role of Ga-68-FAPI PET/CT for Patients with Malignancies of the Lower Gastrointestinal Tract: First Clinical Experience

The Role of 68Ga-FAPI PET/CT for Patients with Malignancies of the Lower Gastrointestinal Tract (LGT): First Clinical Experience seems to be a highly promising...

News

Cancer awareness month – September, don’t forget to remember

The month of September represents the prostate cancer, thyroid cancer, leukemia and lymphoma, and female cancer awareness month. Thus, an important way of supporting...

News

First patients dosed in clinical trial of novel lung and ovarian cancer theranostic

Telix Pharmaceuticals Limited announced that the first two patients have been dosed in a phase I study of the novel lung and ovarian cancer...

News

Sirtex Medical and China Grand Pharmaceutical announce landmark drug registration milestone

Sirtex Medical (“Sirtex”) is a leading manufacturer of targeted liver cancer therapies. It announced today that Sirtex and its shareholders have been issued a...

News

Efficacy and safety of 225 Ac-PSMA-617 TAT in Prostate Cancer

PubMed, July 23, 2020 Despite the success of several standards of care treatment options in metastatic castration-resistant prostate cancer (mCRPC), a significant number of patients...

News

Astatine is a chemistry puzzle that shows anticancer promise

c&en, chemical & engineering news, august 13, 2020. Astatine is the rarest naturally occurring element on Earth. It resists easy chemical classification. In reactions, it...

News

This is not a simple flower, this is an Oncidium

Ever wondered the meaning behind the name and logo of the Oncidium foundation? This is not a flower, this is an Oncidium. A kind of...

News

Webinar Theranostics and PET Imaging Diagnostics

Webinar Theranostics and PET Imaging Diagnostics by IBA RadioPharma Solutions Watch this instructive webinar on the use of PET radiopharmaceuticals in Theranostic applications....

News

Theranostics continue to gain momentum

Article by Richard Zimmermann, President & Founder of the Oncidium foundation. Radiotheranostics are molecules that can safely carry radioactive isotopes inside targeted human...

News

In memory of Sanjiv Sam Gambhir, a leader in the development of precision oncology

Molecular imaging pioneer Sanjiv Sam Gambhir, MD, PhD, passed away on Saturday, July 18, from cancer. He was 57. From the earliest days of his...

News

Another milestone for the Oncidium foundation

Another milestone for the Oncidium foundation: 200 registered hospitals and counting! Thank you to all the nuclear medicine experts that registered their treatment center using...

News

The Oncidium foundation supports the SVIMS

In India, the Sri Venkateswara Institute of Medical Sciences (SVIMS), is a University Hospital based in Tirupati. The city is home to most famous...

Events

SNMMI 2020 – Virtual Edition

Event: SNMMI 2020 Annual Meeting - Virtual Edition Date: 11-14 July 2020 The Oncidium foundation will be virtually attending and holding a booth. Find us under...

News

Atomic Nanogenerators in Targeted Alpha Therapy

Atomic in vivo nanogenerators such as actinium-225, thorium-227, and radium-223 are of increasing interest and importance in Targeted Alpha Therapy (TAT), in the treatment...

News

Postponing PRRT treatment during COVID 19

Postponing PRRT in Neuroendocrine tumors during COVID-19. What do you think? Check out the interesting responses of experts in the field. Read more >>

News

ProsTIC – The new Centre of Excellence

Congratulations Peter MacCallum Cancer Centre for the launch of The Prostate Theranostics & Imaging Centre of Excellence. ProsTIC will lead state-of-the-art research to deliver new...

News

Prostate Cancer Theranostics – An Overview

The implementation of theranostic approaches to characterize and personalize patient management is beginning to be realized for prostate cancer patients. This review article summarized...

News

TheraP Trial Design in Prostate Cancer

Interesting interview with Pr. Michael Hofman about TheraP Trial Design Evaluating 177Lu‐PSMA‐617 Theranostic Treatment vs Cabazitaxel in Progressive Metastatic Castration‐Resistant Prostate Cancer, where results are...

News

Oncidium Spring NEWSLETTER

Fresh news about Oncidium and Radiotheranostics, close up on Neuroendocrine Cancer UK, meet the Oncidium Ambassadors and much more! >> Discover the Newsletter

News

Covid19 – Stay safe

Today, we would like to raise awareness of a different nature, equally important. We hope your relatives and you are well and healthy. The...

News

The Oncidium foundation goes live !

After six months of hard labor, research and discussions, welcome to the Oncidium’s new website! The entire website has been face-lifted in a user-friendly way...

News

World Cancer Day

The 4th of February is the World Cancer Day. Let's increase opportunities to build global awareness and impact-driven action. Keep strong, keep believing, keep...

Events

EANM FOCUS MEETING – Theranostics for NET’s

Event: EANM FOCUS 3 - Molecular Imaging and Theranostics in Neuroendocrine tumours Date: Jan 30 - Feb 01, 2020 Location: Athens, Greece In-depth overview of the latest...

News

Radiolabeled PSMA PET for Renal Cancer

Promising results regarding the role of Radiolabeled PSMA PET as an imaging modality for the evaluation of widespread disease and response to target and...

News

How Radiotheranostics work?

Still wondering how Radiotheranostics work? Read this very interesting and accessible article by the International Atomic Energy Agency (IAEA):“It is a very efficient approach...

News

Strong potential of targeted α-therapy with 225Ac-PSMA-617

Targeted α-therapy with 225Ac-PSMA-617 although still preliminary, has demonstrated strong potential to significantly benefit advanced-stage prostate cancer patients. Dr. Machaba Michael Sathekge comments the...

News

Merry Christmas and Happy New Year

What a year! Looking back at 2019, we were able to start The Oncidium foundation activities, build a motivated team, meet wonderful dedicated people...

Events

ARAB HEALTH 2020

Event: Arab Health 2020 Date: 27 - 30 January 2020 Location: UAE - Dubai World Trade Center

Events

SNMICON 2019

Event: Oncidium Talk during SNMICOM Date: 14 December 2019 Time: 10.40-10.55 AM Location: Hall B, The Majestic The LaLit, Sahar Airport Rd, Mumbai, India

Events

International Symposium Bad Berka 2019

Event: The Inauguration of the ICPO Foundation & The 20th Anniversary of Molecular Radiotherapy Date: 12-14 December 2019 Location: Zentralklinik, Bad Berka

News

Happy Thanksgiving

This year, Oncidium has a lot to be thankful for! We have been able to start our activities around the promotion of Radiotheranostics. First...

News

Promising results for prostate cancer response to PRLT

First promising results on a pilot experience suggest that a single course of tandem therapy with low-activity 225Ac-PSMA-617/full-activity 177Lu-PSMA-617 may safely enhance response to...

News

A dedicated Oncidium’s Ambassador at ALASBIMN 2019

We could not have missed the XXVII Congress of ALASBIMN 2019 in Lima, Peru! Such an important congress at the regional level that brings...

News

EANM commitment: learning from the UK experience

Patient/public involvement and engagement (PPI/PE) incorporates and integrates individual’s perspectives in the planning and improvement of healthcare services and research: “No matter how complicated...

Oncidium foundation @OncidiumFoundat

4 weeks ago
This year has shown us more than ever the importance of #access #education & #hope. The #oncidiumfoundation team put on their most beautiful smile to wish you a hopeful & healthy new year 😊 Looking forward to a fruitful & pivotal #2021 https://t.co/nbbnvo1FpX

View on Twitter

Oncidium foundation @OncidiumFoundat

4 weeks ago
300 hospitals registered! Thank you to all #nuclearmedicine experts that registered their treatment center using #theranostics technologies for #cancercare.
Help patients worldwide contact you by registering your center on the #oncidiumfoundation map 👇
https://t.co/FciqeOscuT https://t.co/Bb8CDOtNu1

View on Twitter

Oncidium foundation @OncidiumFoundat

1 month ago
Ac-225-PSMA-617 showed measurable #antitumor effect after Lu-177-PSMA failure in late-stage Metastatic Castration-resistant #ProstateCancer.
#radiotheranostics #theranostics #precisiononcology #nuclearmedicine #cancercare #radionuclides #radioligandtherapy
https://t.co/oV4bMKmVit

View on Twitter

Oncidium foundation @OncidiumFoundat

1 month ago
Last month was held the first #oncidiumfoundation Ambassadors meeting. Gathered from all around the world, these voices of #theranostics exchanged their ideas, exposed their projects for the work of the foundation. Who will be our next Ambassadors?👇
https://t.co/45YIXYjXfh https://t.co/NCSoguhAAO

View on Twitter

LATEST NEWS AND EVENTS

CONNECT WITH US